Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers

doi:10.1016/S0009-8981(00)00182-0

CSMUIR > Medical College > The Institute of Biochemistry, Microbiology and Immunology > Journal Paper > Item 310902500/11582

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/11582

Title:	Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers
Authors:	Kuo, Wu-Hsien Chou, Fen-Pi Lu, Shio-Chin Chu, Shu-Chen Hsieh, Yih-Shou
Contributors:	中山醫學大學
Keywords:	HCV;HBV;MMP-2;MMP-9
Date:	2000
Issue Date:	2015-07-23T08:21:32Z (UTC)
ISSN:	0009-8981
Abstract:	ABSTRACT To examine the possible involvement of MMP-9 and -2 in the development of liver diseases caused by HCV or HBV infection, serum activities of both enzymes were studied by zymograph. Eight groups of subjects (60 for each) were examined in the study: healthy control, patients with hepatoma, liver cirrhosis, chronic hepatitis B or chronic hepatitis C, and carriers positive for HBsAg, both HBsAg and HBeAg, or anti-HCV. The results showed significant changes in the MMP-9 and -2 activities in the carriers. The presence of HBeAg was accompanied by a highest activity of MMP-2 and an inversely correlated (r=−0.578, P=<0.001), lowest activity of MMP-9 among all groups. For those with active liver diseases, MMPs activities were fluctuated at each stage of pathological symptoms. Chronic hepatitis B and C patients had significant different serum MMP-2 and -9 activities. These findings imply an influence on the balance of MMPs system by the existence of virus that might influence the following progression of liver disease, and a distinction between the pathological mechanisms of HCV and HBV. Since the serum MMPs activities were significantly varied between each stage of liver disease, an individual profile of these parameters might serve as an easy accessing serum marker to monitor the progression of liver disease. Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers. Available from: http://www.researchgate.net/publication/223923342_Significant_differences_in_serum_activities_of_matrix_metalloproteinase-2_and_-9_between_HCV-_and_HBV-infected_patients_and_carriers [accessed Jul 23, 2015].
URI:	https://ir.csmu.edu.tw:8080/ir/handle/310902500/11582 http://dx.doi.org/10.1016/S0009-8981(00)00182-0
Relation:	Clinica Chimica Acta (Impact Factor: 2.76). 04/2000; 294(1-2):157-168.
Appears in Collections:	[The Institute of Biochemistry, Microbiology and Immunology ] Journal Paper

Files in This Item:

File	Description	Size	Format
index.html	期刊論文	0Kb	HTML	310	View/Open

View Licence

Loading...